Immunome Inc expected to post a loss of 39 cents a share - Earnings Preview

Immunome

05/08/2024 16:22

* Immunome Inc  IMNM.OQ   IMNM.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 7
(estimated) for the period ending June 30 2024
    * The Bothell Washington-based  company is expected to
report a
40.2% decrease in revenue to $2.55 million from $4.26 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Immunome Inc is for a
loss
of 39 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunome
Inc is
$34.00​, above​ its last closing price of $13.79. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.78       -0.69      -2.51     Missed  -261.8
 Dec. 31 2024  -0.28       -0.28      -4.22     Missed  -1,389
                                                        .4
                                                        ​
 Jun. 30 2023  -0.16       -0.16      -0.46     Missed  -187.5
 ​​Mar.        0.58        0.59       -0.35     Missed  -159.8
 31 2023                                                
 Dec. 31 2022  -0.68       -0.67      -0.64     Beat    5.2​
 Sep. 30 2022  -0.76       -0.76      -0.75     Beat    1.3
 Jun. 30 2022  -0.76       -0.75      -0.74     Beat    1.3
 This summary was machine generated August 5 at 15:22 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)